These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3940479)

  • 1. Pneumococcal vaccine. Health and Public Policy Committee, American College of Physicians.
    Ann Intern Med; 1986 Jan; 104(1):118-20. PubMed ID: 3940479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal vaccine recommendation. American College of Physicians; Philadelphia, Pennsylvania Endorsed by the advisory committee on immunization practices, council of medical societies.
    Ann Intern Med; 1982 Feb; 96(2):206-7. PubMed ID: 7059068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
    Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
    Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
    Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any connection between a second pneumonia shot and hospitalization among Medicare beneficiaries?
    Snow R; Babish JD; McBean AM
    Public Health Rep; 1995; 110(6):720-5. PubMed ID: 8570826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
    Simberkoff MS
    Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
    Fedson DS
    Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia.
    Musher DM; Rueda-Jaimes AM; Graviss EA; Rodriguez-Barradas MC
    Clin Infect Dis; 2006 Oct; 43(8):1004-8. PubMed ID: 16983612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
    Weycker D; Richardson E; Oster G
    Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
    Mangtani P; Roberts JA; Hall AJ; Cutts FT
    Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal polysaccharide vaccine. Recommendation of the Immunization Practices Advisory Committee.
    Ann Intern Med; 1982 Feb; 96(2):203-5. PubMed ID: 6277218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia.
    Hedlund JU; Kalin ME; Ortqvist AB; Henrichsen J
    Arch Intern Med; 1994 Sep; 154(17):1961-5. PubMed ID: 8074600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
    Kruspe R; Lillis R; Daberkow DW; Blais CM; Wilbright W; Gupta S; Gould CA; Sun T; Martinez JA; deBoisblanc B; Ladabaum U; Sanders CV; Lopez FA
    J La State Med Soc; 2003; 155(6):325-31. PubMed ID: 14750752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of community-acquired pneumonia in adults].
    Barros M M; Cartagena S C; Bavestrello F L
    Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The elderly should be vaccinated against pneumococci].
    Ortqvist A; Hedlund J; Kalin M
    Lakartidningen; 1999 Mar; 96(11):1305-8. PubMed ID: 10194909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
    López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
    J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccination.
    Williams RM
    Lippincotts Prim Care Pract; 1998; 2(6):625-33. PubMed ID: 9883157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of the elderly from pneumococcal pneumonia with a protein-based vaccine?
    Briles DE
    Mech Ageing Dev; 2004 Feb; 125(2):129-31. PubMed ID: 15037017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.